EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mucosal Immunity: The Key to Combating Enteroviruses and Beyond

Nida Kalam iD, Vinod R M T Balasubramaniam iD

Journal of Immunology Research · 2026-01 · 2026 (1)

DOI: 10.1155/jimr/4856137 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Immunology Research, online erschienen am 18.08.2026. Verfasst von Nida Kalam und 1 weiteren Autor:innen. Beteiligte Einrichtung: Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway 47500, Selangor, Malaysia, mona…. Hauptthemen laut MEDLINE: Immunity, Mucosal, Enterovirus Infections, Viral Vaccines, Enterovirus. Die Arbeit nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Monash University, Council of Australasian University Librarians.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enteroviruses (EVs) lead to 10–15 million symptomatic infections each year in the United States alone. EVs enter through either the gastrointestinal or respiratory mucosa, depending on the specific virus. Since these mucosal surfaces are the primary entry points for viruses, mucosal immunity serves as a crucial first line of defense. Nevertheless, the mechanisms that drive it are poorly understood for most EVs. Conventional intramuscular vaccines provide limited protection at these sites, leaving them unprotected; mucosal vaccination addresses this issue directly by generating local SIgA in GALT/NALT that neutralizes pathogens before they spread systemically, while also offering advantages in accessibility and cost. This is not merely theoretical; oral vaccines for polio and rotavirus have already shown the effectiveness of mucosal immunization at scale for enteric viral diseases. This review explores innate pattern recognition through TLR3, RIG‐I, and MDA5 pathways, type I/III interferon (IFN) signaling, and mucosal SIgA responses across key EVs. It also assesses current mucosal vaccine candidates for EV‐A71, CVA16, and EV‐D68, most of which remain in preclinical stages. Understanding of these mechanistic gaps is important for advancing successful mucosal vaccine strategies into effective next‐generation vaccines for EVs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, MucosalEnterovirus InfectionsViral VaccinesEnterovirusHumansAnimalsVaccinationInnate Immunity Recognition

Stichwörter der Autor:innen

echovirusenterovirusenterovirus A71 (EV-A71)enterovirus D68 (EV-D68)gut-associated lymphoid tissue (GALT)human rhinovirus (HRV)innate immune evasionmucosal immunitymucosal vaccinenasal-associated lymphoid tissue (NALT)oral poliovirus vaccineoral rotavirus vaccinepoliovirus (PV)secretory IgA (SIgA)type I interferon (type I IFN)

Substanzen

Viral Vaccines

Autor:innen und Institutionen

  • Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway 47500, Selangor, Malaysia, monash.edu.my.

ORCID-Profile: Nida Kalam, Vinod R M T Balasubramaniam

Förderung

  • Monash University
  • Council of Australasian University Librarians

Zitieren

APA

Kalam, N., & Balasubramaniam, V. R. M. T. (2026). Mucosal Immunity: The Key to Combating Enteroviruses and Beyond. Journal of Immunology Research, 2026(1). https://doi.org/10.1155/jimr/4856137

Vancouver

Kalam N, Balasubramaniam VRMT. Mucosal Immunity: The Key to Combating Enteroviruses and Beyond. Journal of Immunology Research. 2026;2026(1). doi:10.1155/jimr/4856137

BibTeX
@article{Kalam2026,
  author = {Kalam, Nida and Balasubramaniam, Vinod R M T},
  title = {Mucosal Immunity: The Key to Combating Enteroviruses and Beyond},
  journal = {Journal of Immunology Research},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jimr/4856137}
}
Kostenlos starten →